Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Accurately diagnosing and comprehensively managing MS.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases.
Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in Relapsing-Remitting Multiple Sclerosis.
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033.
Mitochondrial complex I gene variations; as a potential genetic risk factor in pathogenesis of multiple sclerosis.
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis.
Autoimmune disease: A role for new anti-viral therapies?
How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?
Glia in the pathogenesis of neurodegenerative diseases.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain.
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Therapy optimization: a new model for managing high-cost biologics.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Pages
« first
‹ previous
…
313
314
315
316
317
318
319
320
321
…
next ›
last »